TScan Therapeutics (NASDAQ:TCRX – Get Free Report) and Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends. Risk and Volatility TScan Therapeutics has a […]